What is OSUR's health score?

ORASURE TECHNOLOGIES INC (OSUR) has a TradeApes health score of 44 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is OSUR's estimated fair value?

Based on our 5-year discounted cash flow model, ORASURE TECHNOLOGIES INC's estimated fair value is $9.15 per share, representing a 115.4% upside from the current price. This is a model estimate, not a price target or investment recommendation.

Is OSUR undervalued or overvalued?

Our model currently rates OSUR as Undervalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

To Unlock Full Report

4 free score cards remaining

ORASURE TECHNOLOGIES INC (OSUR)

Healthcare Undervalued low weak

$4.25

Updated: 2026-07-16

TradeApes Score

Financial Strength

40 Weak

Operating Trend

40 Weak

Relative Value

40 Weak

Capital Allocation

40 Weak

Risk Management

80 Strong

Est. Fair Value $9.15

DCF Upside +115.4%

Sector Rank #676 of 12113

Key Findings

+ Strong liquidity — current assets more than 2× current liabilities

Unlock Full Report →

− Large FCF burn — cash consumption exceeds 10% of revenue

Unlock Full Report →

Industry Related Stocks

Adagio Medical Holdings, Inc. (ADGM) ADM TRONICS UNLIMITED, INC. (ADMT) AETHLON MEDICAL INC (AEMD) Axe Compute Inc. (AGPU) ALIGN TECHNOLOGY INC (ALGN) ALLURION TECHNOLOGIES, INC. (ALUR)

See all Healthcare stocks →

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.